Cybin (HELP) Total Debt (2021)
Cybin (HELP) reported Total Debt of $2.4 million for Q4 2021, up 730.83% quarter-over-quarter from $288370.6 in Q3 2021.
Cybin (HELP) Total Debt (2021) Analysis & Trends
Cybin has reported Total Debt for 1 years, with the latest figure at $2.4 million in Q4 2021.
- For the quarter ending Q4 2021, Total Debt changed N/A year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2021 stood at $2.4 million (changed N/A YoY), and the FY2021 full-year result was $864368.4, changed N/A from the prior year.
- Total Debt for Q4 2021 stood at $2.4 million, up from $288370.6 in the prior quarter.
- The five-year high for Total Debt was $2.4 million in Q4 2021, with the low at $288370.6 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 288,370.58 |
| Jun 30, 2021 | 626,415.91 |
| Mar 31, 2021 | 864,368.44 |